Literature DB >> 16782355

Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke.

Songlin Li1, S Thomas Carmichael.   

Abstract

Aged individuals exhibit reduced functional recovery after stroke. We examined the expression profile in aged animals of a recently identified group of growth-associated genes that underlies post-stroke axonal sprouting in the young adult. Basal levels of most growth-promoting genes are higher in aged cortex compared with young adult, and are further induced after stroke. Compared with the young adult, these genes are induced at later time points after stroke. For growth-inhibitory molecules, myelin-associated glycoprotein and ephrin A5 are uniquely induced in the aged brain; chondroitin sulfate proteoglycans and oligodendrocyte myelin glycoprotein are induced at earlier time points; and Nogo-A, semaphorin IIIa and NG2 decline in aged vs. young adult after stroke. The aged brain does not simply have a reduction in growth-associated molecules after stroke, but a completely unique molecular profile of post-stroke axonal sprouting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782355     DOI: 10.1016/j.nbd.2006.03.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  53 in total

1.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

2.  Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Authors:  J P Sarkey; M Chu; M McShane; E Bovo; Y Ait Mou; A V Zima; P P de Tombe; G L Kartje; J L Martin
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

3.  Executive dysfunction and blockage of brain microvessels in a rat model of vascular cognitive impairment.

Authors:  Kristopher D Langdon; Chris A Cordova; Shirley Granter-Button; Jamie D Boyd; James Peeling; Timothy H Murphy; Dale Corbett
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-30       Impact factor: 6.200

Review 4.  New Directions in Treatments Targeting Stroke Recovery.

Authors:  David J Lin; Seth P Finklestein; Steven C Cramer
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 5.  Thymosin β4 for the treatment of acute stroke: neurorestorative or neuroprotective?

Authors:  Daniel C Morris; Zheng G Zhang; Michael Chopp
Journal:  Expert Opin Biol Ther       Date:  2018-07       Impact factor: 4.388

6.  Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasion.

Authors:  Atul K Johri; Immaculada Margarit; Mark Broenstrup; Cecilia Brettoni; Lei Hua; Steven P Gygi; John L Telford; Guido Grandi; Lawrence C Paoletti
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

7.  Thymosin β4 for the treatment of acute stroke in aged rats.

Authors:  Daniel C Morris; Wing Lee Cheung; Richard Loi; Talan Zhang; Mei Lu; Zheng G Zhang; Michael Chopp
Journal:  Neurosci Lett       Date:  2017-08-31       Impact factor: 3.046

8.  Treatment with Mesenchymal-Derived Extracellular Vesicles Reduces Injury-Related Pathology in Pyramidal Neurons of Monkey Perilesional Ventral Premotor Cortex.

Authors:  Maria Medalla; Wayne Chang; Samantha M Calderazzo; Veronica Go; Alexandra Tsolias; Joseph W Goodliffe; Dhruba Pathak; Diego De Alba; Monica Pessina; Douglas L Rosene; Benjamin Buller; Tara L Moore
Journal:  J Neurosci       Date:  2020-04-02       Impact factor: 6.167

Review 9.  Monoclonal antibody as an emerging therapy for acute ischemic stroke.

Authors:  Demi Woods; Qian Jiang; Xiang-Ping Chu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-08-25

Review 10.  Promoting axonal rewiring to improve outcome after stroke.

Authors:  Larry I Benowitz; S Thomas Carmichael
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.